Alpine Immune Sciences (ALPN) is a clinical stage biopharmaceutical company headquartered in Seattle, WA. Founded in 2015, we are dedicated to discovering and developing innovative, protein-based immunotherapies targeting the immune synapse to treat autoimmune and inflammatory diseases. We have two drugs in the clinic for inflammatory diseases, collaborations with world-class partners, and a robust development pipeline including early-stage trials in ITP, wAIHA and CAD.